Glenmede Trust’s Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6.00% Mandatory Convertible Preferred Stock, Series B BDXB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,151
Closed -$54K 1355
2022
Q3
$54K Hold
1,151
﹤0.01% 1175
2022
Q2
$56K Buy
+1,151
New +$59K ﹤0.01% 1186

Other funds holding BDXB

Glenmede Trust's BDXB Position: Q4 2022 in Review

Glenmede Trust sold out of Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6.00% Mandatory Convertible Preferred Stock, Series B (BDXB) in Q4 2022, closing a stake of 1,151 shares — an estimated $54K sold.

Glenmede Trust first reported a position in BDXB in Q2 2022 and held it in 2 quarters. The position peaked at $56K in Q2 2022. 87 funds tracked by Wall St. Rank hold BDXB as of Q4 2022.

  • Glenmede Trust reported no remaining Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6.00% Mandatory Convertible Preferred Stock, Series B position as of Q4 2022 after selling out during the quarter.
  • Glenmede Trust sold 1,151 Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6.00% Mandatory Convertible Preferred Stock, Series B shares in Q4 2022, an estimated $54K.
  • Glenmede Trust first reported a position in Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6.00% Mandatory Convertible Preferred Stock, Series B in Q2 2022 and held it in 2 quarters.
  • Glenmede Trust's Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6.00% Mandatory Convertible Preferred Stock, Series B position peaked at $56K in Q2 2022.
  • 87 funds tracked by Wall St. Rank held Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6.00% Mandatory Convertible Preferred Stock, Series B as of Q4 2022.

Based on Glenmede Trust's 13F filing for Q4 2022, filed 14 Feb 2023.